TNF and prostate carcinoma: The same results are obtained in DU145 prostate cancer cells where piceatannol inhibited tumor necrosis factor-α (TNF-α)-induced invasion by suppressing MMP-9 activation via the AKT-mediated NF-κB pathway [159].